Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

Comparing Real-World Effectiveness of Leading Knee Gel Injection Brands: Evidence, Ingredients, and Patient Perspectives

Introduction to Knee Gel Injections for Osteoarthritis

Knee osteoarthritis is a common condition that causes joint pain, stiffness, and reduced mobility, especially in older adults. Many people seek gentle, non-surgical treatments to manage these symptoms. One popular option is hyaluronic acid knee injections, also known as viscosupplementation. These injections add a gel-like substance to the joint to help lubricate and cushion it, easing discomfort and improving movement. With so many brands available, it’s important for patients and carers to have clear and unbiased information about how effective these treatments truly are in everyday use. This article explores the leading knee gel injection brands to help guide informed decisions.

Overview of Popular Knee Gel Injection Brands

The market offers several well-known brands designed to relieve knee osteoarthritis symptoms. These include Synvisc, Euflexxa, Durolane, and Monovisc. All of these work by supplementing the knee’s natural hyaluronic acid, which acts like a lubricant and shock absorber for the joint. Their minimally invasive nature and ability to potentially delay surgery make them attractive options for many patients. People often consult knee injection reviews to get a sense of how well these treatments work and what to expect. Beyond these familiar names, a newer product called Arthrosamid has recently become available in the UK, bringing fresh hope with encouraging early results.

Differences in Formulation and Administration

What sets these knee gel injections apart are their ingredients and how they are administered. For example, Synvisc is made from bird-derived (avian) sources, so it might not be suitable for those with allergies to eggs. In comparison, Durolane and Monovisc use synthetic, non-avian hyaluronic acid, making them safer alternatives for people with such sensitivities. Another key difference is the injection schedule: Durolane and Monovisc generally require just one injection per treatment cycle, while Synvisc and Euflexxa usually involve multiple injections spaced over a few weeks. This can affect convenience and the overall treatment experience. Arthrosamid, meanwhile, uses a different substance — polyacrylamide hydrogel — which “adheres to and bulks up the synovial membrane and acts as a scaffold to treat the synovium,” offering a unique approach to joint repair.

Clinical Effectiveness and Patient Outcomes

Research shows that knee gel injections can significantly relieve pain and improve joint function for several months, often up to a year. Single-injection products like Durolane and Monovisc have been found to perform just as well as, or sometimes better than, multi-injection treatments like Synvisc and Euflexxa. Patients typically report noticeable symptom relief and greater mobility regardless of the brand used.

Focusing on Arthrosamid, a recent review highlighted that “the efficacy of PAAG hydrogel at one year post injection” is promising and that “this PAAG hydrogel seems to be an efficacious and safe treatment option for knee OA and provides positive results for at least 2 years.” Additional studies comparing Arthrosamid to traditional hyaluronic acid injections found that it “offers comparable short-term efficacy and modest advantage at 6 months; however, long-term superiority is limited.” Interestingly, this treatment “showed the highest patient acceptable symptom state rates (72%, 54%, and 42% at 3, 6, and 12 months),” indicating strong patient satisfaction over time. Taken together, these findings suggest Arthrosamid is a valuable option, particularly as part of personalised treatment plans. Side effects across all brands tend to be mild and short-lived, often involving temporary joint swelling or minor discomfort shortly after injection.

Choosing the Right Brand: Suitability and Safety Considerations

Choosing the best knee gel injection depends on a few important factors, including safety and individual health needs. For example, people allergic to bird proteins should avoid avian-derived products like Synvisc. Past reactions to injections, overall health, and lifestyle also influence which treatment might work best. The best outcomes often come when patients discuss their options openly with healthcare professionals, who can tailor recommendations based on the latest evidence and individual preferences. Understanding the goals and possible side effects beforehand helps patients make confident, informed choices.

Conclusion: Personalised Care in Osteoarthritis Management

In summary, all leading knee gel injection brands provide effective relief for osteoarthritis symptoms, though each has unique characteristics relating to their ingredients, treatment schedules, and clinical outcomes. While some may suit particular patients better than others, no single product is perfect for everyone. The best approach is a personalised one, where patients consult closely with their healthcare providers to find a treatment that matches their specific needs and circumstances. Being well informed empowers patients to take an active role in managing their knee osteoarthritis, improving both safety and quality of life.

References

Cole, A., Maulana, R. K., Whitehead, J. P., & Lee, P. Y. F. (2022). A systematic review of the novel compound Arthrosamid polyacrylamide (PAAG) hydrogel for treatment of knee osteoarthritis. Medical Research Archives, 10(8). https://doi.org/10.18103/mra.v10i8.2950

Bliddal, H., Beier, J., Hartkopp, A., Conaghan, P. G., & Henriksen, M. (2023). Polyacrylamide hydrogel versus hyaluronic acid in knee osteoarthritis: A subgroup analysis of a randomized study. Orthopaedic Proceedings, 105-B(SUPP_13), 81–81. https://doi.org/10.1302/1358-992x.2023.13.081

Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine, 104(38), e44655. https://doi.org/10.1097/md.0000000000044655

Frequently Asked Questions

AMSK Clinic is distinguished by its experienced team and access to leading knee gel injection brands. The clinic offers a personalised approach, using the latest advances such as Arthrosamid® to help relieve knee osteoarthritis symptoms safely and effectively for diverse patient needs.

AMSK Clinic provides several top brands, including Synvisc, Euflexxa, Durolane, Monovisc, and Arthrosamid®. Differences involve their composition, injection schedule, and suitability for allergies, allowing AMSK Clinic clinicians to tailor solutions for each patient’s unique health circumstances and preferences.

Yes, AMSK Clinic carefully evaluates allergy risks when recommending knee gel injections. For example, Durolane and Monovisc are synthetic and suitable for those with avian allergies, while Synvisc contains bird-derived ingredients. AMSK Clinic’s expertise ensures your safety and a personalised treatment experience.

Patients at AMSK Clinic frequently experience reduced joint pain, improved mobility, and a better quality of life. Clinical studies show all leading brands, including Arthrosamid®, help manage symptoms for months, with side effects usually mild and short-lived. AMSK Clinic’s dedicated care supports positive outcomes.

AMSK Clinic’s specialists discuss each patient’s health needs, preferences, and goals, considering safety and clinical evidence. This personalised approach ensures patients receive guidance on treatments—such as Synvisc, Durolane, or Arthrosamid®—that suit their individual situations, supporting informed and confident healthcare decisions.

Comparing Real-World Effectiveness of Leading Knee Gel Injection Brands: Evidence, Ingredients, and Patient Perspectives

Knee gel injections, including popular brands like Synvisc, Euflexxa, Durolane, Monovisc, and the newer Arthrosamid, offer effective, minimally invasive treatment for osteoarthritis-related knee pain. These injections supplement hyaluronic acid or use alternative hydrogels to lubricate and cushion joints, improving mobility and reducing discomfort. Differences in formulation, administration schedules, and patient suitability guide treatment choices, with synthetic options favored for allergies to avian products. Clinical studies affirm significant symptom relief and high patient satisfaction, especially with Arthrosamid’s unique polyacrylamide hydrogel, which shows promising long-term results. Side effects are generally mild and temporary. Personalized treatment planning with healthcare professionals ensures optimal outcomes, enhancing quality of life for those managing knee osteoarthritis.

Read More »

Unravelling Osteopenia in ICD-10: Accurate Coding and Clinical Implications for British Healthcare Professionals

Osteopenia, characterized by reduced bone mineral density, serves as a critical precursor to osteoporosis and increases fracture risk, especially in postmenopausal women. Accurate ICD-10 coding of osteopenia, including specifying affected sites and menopausal status, is essential in the UK for effective patient management, public health monitoring, and resource allocation within the NHS. Challenges in coding arise due to incomplete records and unclear documentation. Studies indicate that factors like low body weight raise fracture risks among osteopenic patients, underscoring the need for precise coding and thorough clinical documentation. Enhancing screening and coding accuracy ensures timely interventions, improves bone health outcomes, and supports healthcare planning. Ongoing education on osteopenia ICD-10 coding is vital for clinicians and coders to optimize musculoskeletal care delivery in British healthcare.

Read More »